본문 바로가기
KERD
논문KCI 등재

Association between Sarcopenic Obesity and Metabolic Syndrome in Postmenopausal Women: A Cross-sectional Study Based on the Korean National Health and Nutritional Examination Surveys from 2008 to 2011

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류정형외과학

초록

Background: Menopause contributes to an increase in visceral fat mass and a decrease in muscle protein synthesis. Therefore, we performed this study to examine their relationship how effect the changes of body composition as obesity and sarcopenia on metabolic syndrome (MS) as a predictor of cardiovascular disease in postmenopausal women. Methods: Using data from the Korean National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011, we estimated that 4,183 postmenopausal women underwent dual energy X-ray absorptiometry scans. Sarcopenia was defined as an appendicular skeletal muscle mass divided by body weight that was less than 1 standard deviation below the sex specific mean for the young reference group. After classification into four groups, the results were adjusted with menopausal age and hormonal treatment. The relationship between sarcopenic obesity (SO) and MS in postmenopausal women was analyzed by logistic regression analysis in a complex sampling. Results: In an unadjusted model, the odds ratio (OR) of MS for sarcopenia was 1.94 (95% confidence interval [CI], 1.52-2.49); the obesity group had an OR of 4.55 (95% CI, 3.63-5.71); and distinctly, the SO group had an OR of 6.26 (95% CI, 5.10-7.70). Even though there was controlling for variable adjustment, no definite difference was seen in the results. Conclusions: Sarcopenia and obesity were associated with MS independent of other metabolic impairment risk factors in both early menopausal and postmenopausal women. The results showed that, in particular, the prevalence of MS has increased more in postmenopausal women compared with previous research.

Abstract

Background: Menopause contributes to an increase in visceral fat mass and a decrease in muscle protein synthesis. Therefore, we performed this study to examine their relationship how effect the changes of body composition as obesity and sarcopenia on metabolic syndrome (MS) as a predictor of cardiovascular disease in postmenopausal women. Methods: Using data from the Korean National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011, we estimated that 4,183 postmenopausal women underwent dual energy X-ray absorptiometry scans. Sarcopenia was defined as an appendicular skeletal muscle mass divided by body weight that was less than 1 standard deviation below the sex specific mean for the young reference group. After classification into four groups, the results were adjusted with menopausal age and hormonal treatment. The relationship between sarcopenic obesity (SO) and MS in postmenopausal women was analyzed by logistic regression analysis in a complex sampling. Results: In an unadjusted model, the odds ratio (OR) of MS for sarcopenia was 1.94 (95% confidence interval [CI], 1.52-2.49); the obesity group had an OR of 4.55 (95% CI, 3.63-5.71); and distinctly, the SO group had an OR of 6.26 (95% CI, 5.10-7.70). Even though there was controlling for variable adjustment, no definite difference was seen in the results. Conclusions: Sarcopenia and obesity were associated with MS independent of other metabolic impairment risk factors in both early menopausal and postmenopausal women. The results showed that, in particular, the prevalence of MS has increased more in postmenopausal women compared with previous research.

참고문헌 (23)

  1. Lim S, "Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys", Diabetes Care, 28, pp.1810~1812 (2005)
  2. 박은옥, "제 5기 국민건강영양조사로 추정한 한국 성인의 대사증후군 유병률과 관련 요인", 농촌의학.지역보건, 38(1), pp.1~13 (2013), 한국농촌의학.지역보건학회
  3. Kim KM, "Cardiometabolic implication of sarcopenia: the Korea national health and nutrition examination study (KNHANES) 2008-20104", IJC Metab Endocr, pp.63~69 (2014)
  4. Maltais ML, "Changes in muscle mass and strength after menopause", J Musculoskelet Neuronal Interact, 9, pp.186~197 (2009)
  5. Hiroshi Kaji, "Interaction between Muscle and Bone", 대한골대사학회지, 21(1), pp.29~40 (2014), 대한골대사학회
  6. Crawford SL, "A longitudinal study of weight and the menopause transition: results from the Massachusetts Women’s Health Study", Menopause, 7, pp.96~104 (2000)
  7. Stenholm S, "Sarcopenic obesity: definition, cause and consequences", Curr Opin Clin Nutr Metab Care, 11, pp.693~700 (2008)
  8. Lim S, "Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)", Diabetes Care, 33, pp.1652~1654 (2010)
  9. Peppa M, "Association of lean body mass with cardiometabolic risk factors in healthy postmenopausal women", Obesity, 22, pp.828~835 (2014)
  10. 권형준, "Prevalence of Sarcopenia in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys", 대한골대사학회지, 23(1), pp.23~26 (2016), 대한골대사학회[DOI]
  11. 박형무, "Prevalence of Sarcopenia Adjusted Body Mass Index in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys", 대한골대사학회지, 23(4), pp.243~247 (2016), 대한골대사학회[DOI]
  12. Janssen I, "Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability", J Am Geriatr Soc, 50, pp.889~896 (2002)
  13. Baumgartner RN, "Epidemiology of sarcopenia among the elderly in New Mexico", Am J Epidemiol, 147, pp.755~763 (1998)
  14. Grundy SM, "Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute", American Heart Association conference on scientific issues related to definition, 2004, pp.109, 433~438
  15. Alberti KG, "Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation", Diabet Med, 23, pp.469~480 (2006)
  16. Chung JY, "Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity", Arch Gerontol Geriatr, 56, pp.270~278 (2013)
  17. Messier V, "Menopause and sarcopenia: A potential role for sex hormones", Maturitas, 68, pp.331~336 (2011)
  18. Grimby G, "The ageing muscle", Clin Physiol, 3, pp.209~218 (1983)
  19. Hughes VA, "Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health", J Gerontol A Biol Sci Med Sci, 56, pp.B209~B217 (2001)
  20. Goodpaster BH, "The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study", J Gerontol A Biol Sci Med Sci, 61, pp.1059~1064 (2006)
  21. Kim TN, "Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study", Int J Obes, 33, pp.885~892 (2009)
  22. 최경묵, "Sarcopenia and Sarcopenic Obesity", Endocrinology and Metabolism, 28(2), pp.86~89 (2013), 대한내분비학회
  23. 박혜진, "근감소성 비만과 대사증후군과의 관계 : 국가건강영양조사를 중심으로", 석사, 보건정책및병원관리학과, pp.2013

관련 논문AI추천

이 간행물의 다른 논문 (8건)